š¢ This phase Ib/II study investigates the addition of neoadjuvant neratinib to standard therapy in patients with inflammatory #breastcancer, including those with HER2+ and HR+/HER2ā disease across stage III and IV settings.
š Read the full article:
buff.ly/bFwUuVM
#InflammatoryBreastCancer #HER2 #
